Elosulfase alfa

依洛硫酸酯酶α

Report date: 2026/03/23 20:03:44
First In Class

Base Information

Drug NameElosulfase alfa
Drug Alias Name依罗硫酸酯酶αRecombinant N-acetylgalactosamine-6-sulfataseelosulfasum alfaElosulfase alphaElosulfase α +[11] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionN-acetylgalactosamine-6-sulfatase replacementsGlycosaminoglycan degraders
TargetsGlycosaminoglycan
Therapy Area/IndicationsMucopolysaccharidosis IV
Global Approved IndicationsMucopolysaccharidosis IV
Approved Indications in ChinaMucopolysaccharidosis IV
Original Approved Country/TerritoryUnited States
Original Approved Date2014/02/14
Country/TerritoryCanadaUnited StatesTaiwan +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomarin Pharmaceutical IncBiomarin International Ltd
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis IV
Inactive IndicationsN/A

Other Information

ATC CodeA16AB12
Related LinksWikipediaDrugBankKEGG